Methylcobalmine (V-B12) increases cerebral acetylcholine levels and improves passive avoidance response in stroke-prone spontaneously hypertensive rats

Biogenic Amines

Volumn 14, Issue 1, 1998, Pages 15-24

  Kimura, S ^a   Minami, M ^a   Endo, T ^a   Hirafuji, M ^a   Monma, Y ^a   Togashi, H ^b   Saito, H ^b   Parvez, S H ^c  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Acetylcholine; Choline; Passive avoidance task; SHRSP; Vitamin B12

Indexed keywords

ACETYLCHOLINE; CHOLINE; MECOBALAMIN;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; LEARNING; MALE; MULTIINFARCT DEMENTIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; VITAMIN DEFICIENCY;

EID: 6844255882     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Allen, S.J., Benton, J.S., Goodhardt, M J., Haan, E.A., Sims, N.R., Smith, C.C.T., Spillane, J.A., Bowen, D.M. and Davidson, A.N. (1983). Biochemical evidence of selective nerve cell changes in the normal aging human and rat brain. J.Neurochem. 41, 256-265.
2. Artola, A.; Singer, W. (1987). Long-term potentiation and NMDA receptors in rat visual cortex. Nature 330, 649-652.
3. Carmel., R., Gott, P.S., Waters, C.H., Cairo, K., Green, R., Bondareff, W., DeGiorgio, C.M., Cummings, J.L., Jacobsen, D.W. and Buckwalter, G. (1995). The frequently low cobalamine levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur. J. Haematol. 54, 245-253.
4. Carmel, R., Cairo, K., Bondareff, W., Gott, P.S., Cummings, J.L. and Henderson, V.W. (1996). Spouses of demented patients with low cobalamine levels: a new risk group for cobalamine deficiency. Eur. J. Haematol. 57, 62-67.
5. 12 in Alzheimer-type dementia. Age and Ageing 13, 101-105.
6. Collerton, D. (1986). Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-28.
7. Collingridge, G.L.; Kehl, S.J.; McLennan, H. (1983). Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334, 33-46.
8. Coyle, J., Price, D. and DeLong, M. (1983). Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1189.
9. 12 deficiency and dementia. Int. Psychogeriatr. 7, 85-88.
10. Davis, K.L., Hsieh, JY-K., Levy, M.I., Horvath, T.B., Davis, B.M. and Mohs, R.C. (1983). Cerebrospinal acetylchohne, choline and senile dementia of the Alzheimer type. Psychopharmacol. Bull. 18, 193-19.
11. 12 in the elderly. Geront. Clin. 8, 220-225.
12. 12 levels in senile dementia and confusional states. Geront. Clin. 1, 96-106.
13. Gattfreis, C-G, Adorfsson, R., Aquilonius, S-M, Carlsson, A., Eckernäs, S.Å, Nordberg, A., Oreland, L., Svennerholm, L., Wiberg, Å. and Winblad, B. (1983). Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol. Aging 4, 261-271.
14. 3H]dopa in the various regions of the brain. J. Neurochem. 13, 655-669.
15. Gomes, T.C., Regland, B. and Oreland, LK. (1995). Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders. Eur. Neuropsycopharmacol. 5, 107-114.
16. 12 deficiency. J. Neurochem. 40, 1155-1160
17. Hamazaki, T. (1988). Urakaze, M.; Sawazaki, S.; Yamazaki, K.; Taki, H.; Yano, S. Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. Atherosclerosis 73, 157-160.
18. Harris, E.W.; Ganong, A.H.; Cotman, C.W. (1984). Long-term potentiation in the hippocampus involves activation of N-methyl-d-asparate receptors. Brain Res. 323, 132-137.
19. 12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. Acta Psychiatr. Scand. 82, 327-329.
20. Kano, Y., Sakamoto, S., Miura, Y. and Takaku, F. (1985). Disorders of cobalamine metabolism. Crit. Rev. Oncol. Hematol. 3, 1-34.
21. Karnaze, D.S. and Carmel, R. (1987). Low serum cobalamine levels in primary degenerative dementia. Arch. Intern. Med. 429-431.
22. Lindenbaum, J., Healton, E.B., Savage, D.G., Brust, J.C. M. Garret, T.J., Podell, E.R., Marcell, P.D., Stabler, S.P. and Allen, R.H. (1988). Neuropsychiatric disorders caused by cobalamine deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318, 1720-1728.
23. Lowry, O.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Matsumoto, M., Togashi, H., Yoshioka, M., Hirokami, M., Morii, K. and Saito, H. (1990) Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acethylcholine and their metabolites in cerebrospinal fluid of anaesthetized normotensive rats. J. Chromatography. 526, 1-10.
25. Matsumoto, M., Togashi, H., Yoshioka, M., Morii, K., Hirokami, M., Toshihara, M., Ikeda, T., Saito, Y. and Saito, H. (1991). Significant correlation between cerebrospinal fluid and brain levels of norepinephrine, serotonin and acetylcholine in anaesthetized rats. Life Sci. 48, 823-829.
26. McCaddon, A., Regland, B. and Fear, C.F. (1995). Trypsin inhibition: a potential cause of cobalamine deficiency common to the pathologenesis of Alzheimer-typedementia and AIDS dementia complex? Med. Hypotheses 45, 200-204.
27. 12 on behavioral changes in stroke-prone spontaneously hypertensive rats. Biogenic Amines 8, 33-52.
28. 12 on behavioral changes in SHRSP. In: New Advances in SHR Research-Pathophysiology and Pharmacology. Progress in Hypertension vol.3., Saito, H., Yamori, Y., Minami, M. and Parvez, H.S. (Eds), VSP, The Netherlands, pp.173-188.
29. 12 supplementation on choline acetyltransferase activity in cat brain. Internat. J. Vit. Nutr. Res. 58, 402-406.
30. Nishikawa, M.; Kimura, S.; Akaike, N. (1994). Facilitatory effect of docosahexaenoic acid on N-methyl-D-aspartate response in pyramidal neurones of rat cerebral cortex. J. Physiol. 475, 83-93.
31. Perry, E.K. (1980). The cholinergic system in old age and Alzheimer's disease. Age Aging 9, 1-8.
32. 12 ratio in demented men. Acta Neurol. Scand. 85, 276-281.
33. 12 metabolism and deficiency states. J. Fam. Pract. 41, 595-600.
34. Togashi, H., Matsumoto, M., Yoshioka, M., Minami, M. and Saito, H. Behavioral and neurochemical evaluation of stroke-prone spontaneously hypertensive rats for vascular dementia-animal model. In: Basic. Clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Disease, T. Nagatsu et al. (Eds), Vol. 1, Plenum Press. New York, 1990, pp. 473-476.
35. Togashi, H., Matsumoto, M., Yoshioka, M., Hirokami, M., Minami, M. and Saito, H. (1994). Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 166, 117-120.
36. Togashi, H., Kimura, S., Matsumoto, M., Yoshioka, M., Minami, M. and Saito, H. (1996). Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats. Stroke 27(3), 520-525.
37. Wallenstein, S., Zucker, C.L. and Fleiss, J.L. (1980). Some statistical methods useful in circulation research. Circ. Res. 47, 1-9.
38. Wallin, A., Alafuzoff, I., Carlsson, A., Eckernäa, S.-A., Gottfries, C.-G., Karlsson, I., Svennerfolm, L. and Winblad, B. (1989). Neurotransmitter deficits in a non-multi-infarct category of vascular dementia. Acta. Neurol. Scand. 79, 397-406.
39. Yao, Y., Yao, G., Mesches, D.N. and Lou, W. (1994). Decline of serum cobalamine levels with increasing age among geriatiric outpatients. Arch. Fam. Med. 3, 918-922.